Skip to main content

Animations

MJFF Publications

8341 - 8350 of 9034 Results
Title
Year
  • Year
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2019
  • 2020
  • 2019
  • 2020
  • Summary Details
    OPEN
    Title: Fox Insight collects online, longitudinal patient-reported outcomes and genetic data on Parkinson’s disease
    Journal Name: Scientific Data
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41597-020-0401-2
    Citation Count: 111
  • Summary Details
    OPEN
    Title: Safety of Levodopa-Carbidopa Intestinal Gel Treatment in Patients with Advanced Parkinson’s Disease Receiving ≥2000 mg Daily Dose of Levodopa
    Journal Name: Parkinson's Disease
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1155/2020/9716317
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Molecular Signatures of Neuroinflammation Induced by αSynuclein Aggregates in Microglial Cells
    Journal Name: Frontiers in Immunology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fimmu.2020.00033
    Citation Count: 86
  • Summary Details
    OPEN
    Title: Subcortical Intermittent Theta-Burst Stimulation (iTBS) Increases Theta-Power in Dorsolateral Prefrontal Cortex (DLPFC)
    Journal Name: Frontiers in Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnins.2020.00041
    Citation Count: 38
  • Summary Details
    OPEN
    Title: Improvement of classification performance of Parkinson’s disease using shape features for machine learning on dopamine transporter single photon emission computed tomography
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0228289
    Citation Count: 41
  • Summary Details
    OPEN
    Title: Long-term post-mortem studies following neurturin gene therapy in patients with advanced Parkinson’s disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awaa020
    Citation Count: 85
  • Summary Details
    OPEN
    Title: Risk of spread in adult-onset isolated focal dystonia: a prospective international cohort study
    Journal Name: Journal of Neurology, Neurosurgery & Psychiatry
    Publisher: BMJ
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1136/jnnp-2019-321794
    Citation Count: 79
  • Summary Details
    OPEN
    Title: Cerebrospinal fluid proteomics implicates the granin family in Parkinson’s disease
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-020-59414-4
    Citation Count: 100
  • Summary Details
    OPEN
    Title: Distinct tau PET patterns in atrophy‐defined subtypes of Alzheimer's disease
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.jalz.2019.08.201
    Citation Count: 120
  • Summary Details
    OPEN
    Title: Global Landscape and Dynamics of Parkin and USP30-Dependent Ubiquitylomes in iNeurons during Mitophagic Signaling
    Journal Name: Molecular Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.molcel.2019.11.013
    Citation Count: 223
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.